Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Sierra Boughton's doctor insisted her heavy, painful periods were normal, but then at just 24, she received devastating news.

The findings of the study showed that adenocarcinoma, accounted for 53-70 per cent of the lung cancer cases in non-smokers globally in 2022.

While screenings and vaccinations have brought down cervical cancer rates for millions of women, in some age groups, cases have been rising.

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve statistical significance for overall survival in patients with advanced ...

High-risk HPVs cause cervical dysplasia and carcinoma in situ, which if locally confined can be successfully treated but if left untreated can progress to cervical carcinoma. There is usually a ...

Three exposed women (under 30 years of age) with clear cell adenocarcinoma of the vagina were identified (approximately 1:1600 DES daughters), which confirms the incidence rate of adenocarcinoma ...

cervical adenocarcinoma in situ [AIS], and invasive carcinoma), CIN 3, and CIN 3 or worse (CIN 3+, excluding CIN 2). According to the 2009 KPNC cervical cancer screening guidelines, ECC is ...

A mother-of-one is urging people to ensure they have regular cervical screenings, saying that the routine test "truly saved my life". Ali Alcock from Corwen, Denbighshire, said the test led to her ...

Cervical screening tests save thousands of lives each year in the UK, but many women do not take up invitations for screenings A knowledge gap around cervical screenings is currently "costing ...

A knowledge gap around cervical screenings is currently "costing lives", a cancer charity says. The Eve Appeal says more women need to know they can ask for adjustments to their cervical ...